Earnings Feed
Start Free
Regulus Therapeutics Inc.·4

May 8, 8:03 PM ET

Sarissa Capital Offshore Master Fund LP 4

4 · Regulus Therapeutics Inc. · Filed May 8, 2020

Insider Transaction Report

Form 4
Period: 2020-04-01
Regulus Therapeutics Inc.RGLS
Sarissa Capital Offshore Master Fund LP
10% Owner
Transactions
  • Other

    Class A-2 Convertible Preferred Stock

    [F2][F1][F3]
    2020-04-01−5,311→ 262,704 total
    → Common Stock (53,110 underlying)
  • Other

    Warrants to Purchase Common Stock

    [F1][F2][F3]
    2020-04-01−23,243→ 1,149,649 total
    Exercise: $1.08From: 2020-04-01Exp: 2024-05-07→ Common Stock (23,243 underlying)
  • Other

    Warrants to Purchase Common Stock

    [F1][F2][F3]
    2020-04-01−53,113→ 2,627,037 total
    Exercise: $0.67From: 2020-04-01Exp: 2024-12-24→ Common Stock (53,113 underlying)
Footnotes (3)
  • [F1]See Exhibit 99.1.
  • [F2]See Exhibit 99.1.
  • [F3]See Exhibit 99.1.
Signature
/s/ Mark DiPaolo, Authorized Person|2020-05-08

Documents

2 files
  • 4
    doc1.xmlPrimary

    FORM 4

  • EX-99.1
    s34767825.htm

    EXPLANATION OF RESPONSES